e-learning
resources
Paris 2018
Monday, 17.09.2018
Preclinical and clinical studies of critical illness
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Early corticosteroid in influenza pneumonia related acute respiratory distress syndrome treated with extracorporeal membrane oxygenation
Y. Chien (Taipei , Taiwan), C. Chien (Taipei , Taiwan), J. Li (Taipei , Taiwan)
Source:
International Congress 2018 – Preclinical and clinical studies of critical illness
Session:
Preclinical and clinical studies of critical illness
Session type:
Thematic Poster
Number:
2322
Disease area:
Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Chien (Taipei , Taiwan), C. Chien (Taipei , Taiwan), J. Li (Taipei , Taiwan). Early corticosteroid in influenza pneumonia related acute respiratory distress syndrome treated with extracorporeal membrane oxygenation. 2322
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Extracorporeal membrane oxygenation for acute respiratory distress syndrome due to
Pneumocystis
pneumonia
Source: Eur Respir J, 54 (3) 1900410; 10.1183/13993003.00410-2019
Year: 2019
Severe acute respiratory distress syndrome requiring extracorporeal membrane oxygenation support: a consequence of vaping
Source: ERJ Open Res, 6 (2) 00013-2020; 10.1183/23120541.00013-2020
Year: 2020
Extracorporeal membrane oxygenation in a nonintubated patient with acute respiratory distress syndrome
Source: Eur Respir J 2012; 40: 1296-1298
Year: 2012
EOLIA trial: the future of extracorporeal membrane oxygenation in acute respiratory distress syndrome therapy?
Source: Breathe, 15 (3) 244; 10.1183/20734735.0363-2018
Year: 2019
Extracorporeal support for patients with acute respiratory distress syndrome
Source: Eur Respir Rev 2014; 23: 379-389
Year: 2014
Impact of experience and education in treatment of adult respiratory distress syndrome (ARDS) using extracorporeal membrane oxygenation (ECMO)
Source: Annual Congress 2012 - Infections and sepsis in the ICU
Year: 2012
Thirty months’ experience with bicaval dual lumen cannula for venovenous extracorporeal membrane oxygenation in refractory acute respiratory distress syndrome
Source: Annual Congress 2013 –Acute respiratory failure, ARDS and severe COPD exacerbations
Year: 2013
Current invasive ventilatory strategies in acute respiratory distress syndrome
Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=161
Year: 2002
NIV: indication in case of acute hypoxaemic respiratory failure (pulmonary oedema and immunosuppressed patients excluded)
Source: Eur Respir Mon; 2008: 41: 60–71
Year: 2008
Extracorporeal CO2 removal for refractory hypercapnia in acute respiratory failure: A case series
Source: International Congress 2016 – Noninvasive ventilation and beyond: novelties and real-life applications
Year: 2016
Exogenous pulmonary surfactant combined with recruitment maneuver in prevention of alveolar derecruitment in rabbits with acute respiratory distress syndrome
Source: Annual Congress 2007 - Lung recruitment
Year: 2007
Surfactant treatment leads to a sustained improvement of oxygenation only in severe pediatric ARDS without pneumonia
Source: Eur Respir J 2001; 18: Suppl. 33, 318s
Year: 2001
Combined cell therapy and anticoagulants for acute respiratory distress syndrome
Source: Virtual Congress 2020 – Translational therapeutic advances
Year: 2020
Incidence and short-term outcome of acute lung injury in mechanically ventilated children
Source: Eur Respir J 2003 Dec 01;22(6):980-985
Year: 2003
Surfactant therapy in acute lung injury/acute respiratory distress syndrome
Source: Eur Respir Mon 2012; 55: 54-64
Year: 2012
Early intervention with non-invasive respiratory therapies in mild acute respiratory distress syndrome secondary to COVID-19
Source: Virtual Congress 2021 – Non-invasive respiratory support in COVID-19
Year: 2021
Acute increase in KL-6/MUC1 mucin as a potential trigger of disseminated intravascular coagulation in acute respiratory distress syndrome
Source: Annual Congress 2006 - Acute respiratory distress syndrome (ARDS): from pathophysiology to clinical management
Year: 2006
Role of heat shock proteins in the lungs of acute lung injury
Source: Annual Congress 2006 - Acute respiratory distress syndrome (ARDS): from pathophysiology to clinical management
Year: 2006
Noninvasive ventilation in acute lung injury and acute respiratory distress syndrome
Source: Annual Congress 2009 - Controversies of noninvasive ventilation in acute patients
Year: 2009
Exogenous pulmonary surfactant administration for acute respiratory distress syndrome in post-operative patients
Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept